A Randomized, Open-Label, Multicenter, Phase 3 Study To Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination with And/Or Following Chemotherapy in Patients with Previously Untreated Epithelial Ovarian Cancer

Type of Cancer
Ovarian Cancer

Sponsor
Pfizer

Protocol Number
B9991010

To Learn More Call
201-510-0910